A promising targeted therapy for metastatic melanoma with BRAF-V600E mutation

被引：0
|
作者：
Darbon, J. -M.
机构：
来源：
BULLETIN DU CANCER | 2010年 / 97卷 / 12期
关键词：
RAF INHIBITORS; BRAF; CELLS;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1413 / 1414
页数：2
相关论文
共 50 条
  • [41] Overwhelming response to Dabrafenib in a patient with double BRAF mutation (V600E; V600M) metastatic malignant melanoma
    Ponti, Giovanni
    Tomasi, Aldo
    Pellacani, Giovanni
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2012, 5
  • [42] Overwhelming response to Dabrafenib in a patient with double BRAF mutation (V600E; V600M) metastatic malignant melanoma
    Giovanni Ponti
    Aldo Tomasi
    Giovanni Pellacani
    Journal of Hematology & Oncology, 5
  • [43] Detection of the BRAF V600E Mutation in Primary and Metastatic Malignant Melanoma: An Evaluation of the Immunohistochemical Approach
    Fitchford, L. C. K.
    Elsheikh, S.
    JOURNAL OF PATHOLOGY, 2019, 249 : S51 - S51
  • [44] Determination of the mutation BRAF V600E in melanoma patients Uruguayans
    Eugenia Mazzei, Maria
    Hochmann, Jimena
    Manrique, Gonzalo
    Luisa Marino, Ana
    Delgado, Lucia
    Martinez Asuaga, Miguel
    REVISTA MEDICA DEL URUGUAY, 2013, 29 (02): : 97 - 102
  • [45] Sarcoid-like reaction in a BRAF V600E-mutated metastatic melanoma patient during treatment with BRAF/MEK-targeted therapy
    Tijtgat, Jens
    Schwarze, Julia Katharina
    Awada, Gil
    Neyns, Bart
    Aspeslagh, Sandrine
    MELANOMA RESEARCH, 2021, 31 (03) : 272 - 276
  • [46] Determination of the BRAF V600E mutation in Uruguayan melanoma patients
    Eugenia Mazzei, Maria
    Hochman, Jimena
    Manrique, Gonzalo
    Luisa Marino, Ana
    Beatriz Delgado, Lucia
    Angel Martinez, Miguel
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [47] Amelanotic primary dermal melanoma with V600E BRAF mutation
    Kabuto, Miho
    Fujimoto, Noriki
    Teramura, Kazuya
    Nakanishi, Takeshi
    Fujimura, Taku
    Manabe, Toshiaki
    Tanaka, Toshihiro
    DERMATOLOGICA SINICA, 2017, 35 (02) : 110 - 111
  • [48] BRAF-V600E AND P53 MUTATION AS A POTENTIAL PROGNOSTIC MARKERS OF REMISSION DURATION
    Kryachok, I.
    Skrypets, T.
    Novosad, O.
    Khranovska, N.
    Svergun, N.
    Grabovoy, O.
    Antoniuk, S.
    HAEMATOLOGICA, 2015, 100 : 764 - 765
  • [49] Assessment of association between BRAF-V600E mutation status in melanomas and clinical response to ipilimumab
    Shahabi, Vafa
    Whitney, Gena
    Hamid, Omid
    Schmidt, Henrik
    Chasalow, Scott D.
    Alaparthy, Suresh
    Jackson, Jeffrey R.
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2012, 61 (05) : 733 - 737
  • [50] Braf V600E mutation in melanoma: translational current scenario
    J. A. Guadarrama-Orozco
    A. Ortega-Gómez
    E. B. Ruiz-García
    H. Astudillo-de la Vega
    A. Meneses-García
    C. Lopez-Camarillo
    Clinical and Translational Oncology, 2016, 18 : 863 - 871
12345